Over 300 million people live with a rare genetic disease and for most, the journey from the first symptoms to a diagnosis takes more than 5 years. Even after that, diagnoses are often incorrect, and many people end up not being diagnosed at all.
Now, new technology is allowing millions to benefit from genetic testing for diagnosis, while at the same time targeted therapies for previously untreatable disorders are being developed.
But the last step in genetic testing – interpreting mutations – remains laborious and costly. It can take a genetic testing lab weeks to interpret data from a single patient. Because of limited understanding of the consequences of mutations, the test results are often inconclusive and leave 70% of people undergoing a genetic test without diagnosis.
Our platform leverages a unique combination of machine learning and synthetic biology to characterize mutations at scale and automate the interpretation. By offering it to labs, we enable them to diagnose more people in a fraction of the time.
Now, new technology is allowing millions to benefit from genetic testing for diagnosis, while at the same time targeted therapies for previously untreatable disorders are being developed.
But the last step in genetic testing – interpreting mutations – remains laborious and costly. It can take a genetic testing lab weeks to interpret data from a single patient. Because of limited understanding of the consequences of mutations, the test results are often inconclusive and leave 70% of people undergoing a genetic test without diagnosis.
Our platform leverages a unique combination of machine learning and synthetic biology to characterize mutations at scale and automate the interpretation. By offering it to labs, we enable them to diagnose more people in a fraction of the time.
Location: Germany, Berlin
Employees: 11-50
Total raised: $5.73M
Founded date: 2018
Investors 5
| Date | Name | Website |
| 09.02.2022 | 42CAP | 42cap.com |
| 28.06.2022 | MK Venture... | mk-vc.com |
| 03.06.2021 | Creative D... | creativede... |
| - | Acequia Ca... | acecap.com |
| - | Entreprene... | joinef.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.02.2022 | - | $5.73M | - |
Mentions in press and media 8
| Date | Title | Description |
| 27.02.2023 | What Impact Could AI Have On Genetic Testing? | Dr Rocío Acuña Hidalgo, co-founder and CTO at Nostos Genomics The sequencing and analysis of human DNA have advanced significantly since the initial draft of a human genome that was published as part of the Human Genome Project. With DNA se... |
| 04.02.2022 | Roundup: Nostos Genomics raises €5M to speed up genetic disease diagnosis, Canary's rapid test achieves CE mark, and more briefs | Credit: Nostos Genomics |
| 04.02.2022 | What does your genetic data tell about you? Berlin’s Nostos Genomics raises €5 million to speed up disease diagnosis | Berlin-based AI driven genetic analysis platform Nostos Genomics has raised a €5 million seed funding from 42CAP, Frontline Ventures, Amino Collective and Entrepreneur First. Other investors in the round included Konstantin Mehl (Kaia Healt... |
| 03.02.2022 | Berlin-based Nostos Genomics raises €5M to speed up genetic disease diagnosis and market expansion | Nostos Genomics, a Berlin-based genetic analysis platform, has closed a €5M seed round from 42CAP, Frontline Ventures, Amino Collective, and Entrepreneur First. The funding comes after the startup had raised an undisclosed amount in a pre-s... |
| 01.06.2021 | Genomenon and Nostos Genomics Partner to Accelerate Rare Genetic Disease Diagnoses | "This collaboration stemmed from a shared desire to not only provide clinicians with the best decision support possible, but also improve the accuracy, speed, and accessibility of genetic testing to lessen the burden of the diagnostic ... |
| 04.12.2020 | 7 neue Startups, die sich jeder ganz genau merken sollte | Jeden Tag entstehen überall in Deutschland, Österreich und der Schweiz neue Startups. deutsche-startups.de präsentiert an dieser Stelle wieder einmal einige ganz junge Startups, die zuletzt, also in den vergangenen Tagen, Wochen und Monaten... |
| 27.03.2019 | Meet the European startups that pitched at EF’s 11th Demo Day in London | Entrepreneur First (EF), the company builder and “talent first” investor, held its eleventh Demo Day in London this afternoon. The event included newly formed startups from EF’s London, Berlin and Paris cohorts, and represented a showcase o... |
| - | What does your genetic data tell about you? Berlin’s Nostos Genomics raises €5 million to speed up disease diagnosis | Berlin-based AI driven genetic analysis platform Nostos Genomics has raised a €5 million seed funding from 42CAP, Frontline Ventures, Amino Collective and Entrepreneur First. Other investors in the round included Konstantin Mehl (Kaia Healt... |